Henan Newland Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio
Henan Newland Pharmaceutical Co. Ltd. A capital reinvestment ratio. Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Capital Reinvestment Ratio of 0.87x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥116.94 Million) in capital expenditures (CN¥101.38 Million). Check 301277 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Capital reinvestment ratio of Henan Newland Pharmaceutical Co. Ltd. A from 2020 to 2025. This chart tracks Henan Newland Pharmaceutical Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Also explore Henan Newland Pharmaceutical Co. Ltd. A net asset momentum to track the company's year-over-year net asset growth rate.
Henan Newland Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2025)
Henan Newland Pharmaceutical Co. Ltd. A capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see Henan Newland Pharmaceutical Co. Ltd. A cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | CN¥116.94 Million | CN¥101.38 Million | ▼ -0.8% |
| 2024 | 0.87x | CN¥126.76 Million | CN¥110.79 Million | ▲ +135.0% |
| 2023 | 0.37x | CN¥259.46 Million | CN¥96.51 Million | ▼ -58.5% |
| 2022 | 0.90x | CN¥82.85 Million | CN¥74.34 Million | ▲ +73.4% |
| 2021 | 0.52x | CN¥49.08 Million | CN¥25.40 Million | ▲ +46.0% |
| 2020 | 0.35x | CN¥47.86 Million | CN¥16.96 Million | — |